Old Web
English
Sign In
Acemap
>
authorDetail
>
Federico Zazzetti
Federico Zazzetti
Janssen Pharmaceutica
Adverse effect
Psoriatic arthritis
Inflammatory bowel disease
Internal medicine
Guselkumab
1
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced.
2021
RMD Open
Christopher T. Ritchlin
Philip S. Helliwell
Wolf-Henning Boehncke
Enrique R. Soriano
Elizabeth C. Hsia
Alexa P. Kollmeier
Soumya D. Chakravarty
Federico Zazzetti
Ramanand A Subramanian
Xie L. Xu
Qing C Zuraw
S. Sheng
Yusang Jiang
Prasheen Agarwal
B. Zhou
Yanli Zhuang
M. Shawi
Chetan Karyekar
Atul Deodhar
Show All
Source
Cite
Save
Citations (4)
1